ARPKD is usually a severe early onset disease, but there is wide variability in severity even among patients carrying the same PKHD1 mutations, emphasizing the importance of modifying genes and potential environmental factors (Gunay-Aygun et al., 2010). This evidence concerns the gene PKHD1 and autosomal recessive polycystic kidney disease.